Development of Novel Anti-HIV Pyrimidobenzothiazine Derivatives: Springer Theses
Autor Tsukasa Mizuharaen Limba Engleză Hardback – 17 oct 2013
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 360.68 lei 6-8 săpt. | |
Springer – 23 aug 2016 | 360.68 lei 6-8 săpt. | |
Hardback (1) | 365.78 lei 6-8 săpt. | |
Springer – 17 oct 2013 | 365.78 lei 6-8 săpt. |
Din seria Springer Theses
- 5% Preț: 1093.02 lei
- Preț: 369.18 lei
- 15% Preț: 612.38 lei
- 18% Preț: 1155.83 lei
- Preț: 378.35 lei
- 18% Preț: 945.09 lei
- 18% Preț: 891.29 lei
- Preț: 544.53 lei
- 15% Preț: 609.22 lei
- 15% Preț: 608.78 lei
- 15% Preț: 605.10 lei
- 20% Preț: 558.82 lei
- 18% Preț: 892.92 lei
- 18% Preț: 1056.46 lei
- 15% Preț: 606.28 lei
- 15% Preț: 606.28 lei
- Preț: 276.68 lei
- 15% Preț: 602.88 lei
- 18% Preț: 844.04 lei
- 15% Preț: 607.07 lei
- Preț: 369.27 lei
- 20% Preț: 563.89 lei
- Preț: 372.48 lei
- 15% Preț: 604.28 lei
- 15% Preț: 607.57 lei
- 18% Preț: 1052.70 lei
- 20% Preț: 551.36 lei
- 18% Preț: 1045.22 lei
- 18% Preț: 1051.19 lei
- 18% Preț: 1161.04 lei
- 18% Preț: 894.40 lei
- 18% Preț: 893.64 lei
- 15% Preț: 606.28 lei
- 18% Preț: 1163.23 lei
- 15% Preț: 605.86 lei
- 18% Preț: 1152.84 lei
- 15% Preț: 603.21 lei
- 18% Preț: 947.93 lei
- 15% Preț: 602.43 lei
- 15% Preț: 607.07 lei
- Preț: 366.65 lei
- 18% Preț: 946.59 lei
- Preț: 365.05 lei
- Preț: 365.05 lei
- 18% Preț: 1050.46 lei
- 18% Preț: 1051.95 lei
- Preț: 366.45 lei
- 15% Preț: 603.53 lei
- 20% Preț: 554.20 lei
- 20% Preț: 555.57 lei
Preț: 365.78 lei
Nou
Puncte Express: 549
Preț estimativ în valută:
70.02€ • 75.28$ • 58.37£
70.02€ • 75.28$ • 58.37£
Carte tipărită la comandă
Livrare economică 20 decembrie 24 - 03 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9784431544449
ISBN-10: 4431544445
Pagini: 100
Ilustrații: XI, 151 p. 98 illus., 3 illus. in color.
Dimensiuni: 155 x 235 x 15 mm
Greutate: 0.37 kg
Ediția:2013
Editura: Springer
Colecția Springer
Seria Springer Theses
Locul publicării:Tokyo, Japan
ISBN-10: 4431544445
Pagini: 100
Ilustrații: XI, 151 p. 98 illus., 3 illus. in color.
Dimensiuni: 155 x 235 x 15 mm
Greutate: 0.37 kg
Ediția:2013
Editura: Springer
Colecția Springer
Seria Springer Theses
Locul publicării:Tokyo, Japan
Public țintă
ResearchCuprins
Introduction.- Development of Divergent Synthetic Methods of Pyrimidobenzothiazine and Related Tricyclic Heterocycles.- Structure–Activity Relationship Study of PD 404182 Derivatives for the Highly Potent Anti-HIV Agents.- Design and Synthesis of Photoaffinity Probes and Their Application to Target Identification Study of PD 404182.- Conclusion.
Notă biografică
Department of Chemistry
University of Massachusetts Amherst, USA
Ph. D. in Pharmaceutical Sciences
Graduate School of Pharmaceutical Sciences,
Kyoto University, Japan
University of Massachusetts Amherst, USA
Ph. D. in Pharmaceutical Sciences
Graduate School of Pharmaceutical Sciences,
Kyoto University, Japan
Textul de pe ultima copertă
The author successfully developed novel anti-HIV PD 404182 derivatives that exhibited submicromolar inhibitory activity against both HIV-1 and HIV-2. His thesis is in three parts. The first part expounds efficient methods for the synthesis of tricyclic heterocycles related to PD 404182 based on the sp2-carbon−heteroatom bond formations. Starting from arene or haloarene, C-O, C-N, or C-S bonds were formed by simply changing the reactants. These synthetic methods provide powerful approaches for the divergent preparation of pyrimido-benzoxazine, -quinazoline, or -benzothiazine derivatives. The second part explains SAR studies of PD 404182 for the development of anti-HIV agents. Through optimization studies of the central 1,3-thiazin-2-imine core, the benzene and cyclic amidine ring parts, 3-fold more potent inhibitors were obtained compared with the lead compound. The author also reveals by a time-of-drug-addition experiment that PD 404182 derivatives impaired HIV replication at the binding or fusion stage. The third part of the thesis elucidates the development of photoaffinity probes for the target identification of PD 404182. By the photolabeling experiment of HIV-1-infected H9 cells using these probes, the author detected proteins specifically bound to PD 404182. These new anti-HIV agents may be promising agents for anti-HIV therapy because their mechanisms of action differ from those of the currently approved anti-HIV agents.
Caracteristici
Nominated by Kyoto University as an outstanding Ph.D. thesis Divergent synthetic methods that enable efficient structure–activity relationship studies Development of more potent derivatives based on extensive structure-activity relationship studies